Cantai Therapeutics, Inc. — Form D

Cantai Therapeutics, Inc. of PHILADELPIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-15. The offering totals $1.1M, of which $550K was reported sold. Industry: Biotechnology.

Offering

Filed: 2025-07-15
Form: D
Accession: 0001991732-25-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.1M
Amount sold: $550K
Remaining: $550K
Investors: 3
Date of first sale: 2025-07-02
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-551755

Issuer

Name: Cantai Therapeutics, Inc.
CIK: 0001991732
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2023
Address: 3675 MARKET STREET, PHILADELPIA, PA, 19104
Phone: 603-996-1218

Officers, directors & promoters (11)

Name	Role	Location
Errik Anderson	Director	Cambridge, MA
Joshua Brandt	Director	Philadelphia, PA
Ross Leimberg	Director	Philadelphia, PA
Geeta Vemuri	Director	Waltham, MA
Errik Anderson	Executive Officer	Cambridge, MA
Ross Leimberg	Executive Officer	Philadelphia, PA
Geeta Vemuri	Executive Officer	Waltham, MA
Joshua Brandt	Executive Officer	Philadelphia, PA
Errik B. Anderson	Executive Officer	Cambridge, MA
Getta B. Vemuri	Director	Philadelphia, PA
Getta B. Vemuri	Executive Officer	Philadelphia, PA

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2026-01-21	D	$3.0M	$3.0M
2023-11-20	D	$30.0M	$700K
2023-11-20	D/A	$3.0M	$700K

More